 | • レポートコード：MRC2303K075 • 出版社/出版日：Mordor Intelligence / 2023年2月 • レポート形態：英文、PDF、118ページ • 納品方法：Eメール（受注後2-3営業日） • 産業分類：医療 |
| Single User | ￥712,500 (USD4,750) | ▷ お問い合わせ |
| Corporate License | ￥1,312,500 (USD8,750) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| Mordor Intelligence社の調査レポートでは、世界の血行動態モニタリング市場規模が、予測期間中（2022年-2027年）、CAGR 4.55％で増大すると予測されています。本レポートでは、血行動態モニタリングの世界市場を広く調査・分析し、イントロダクション、調査手法、エグゼクティブサマリー、市場動向、システム別（低侵襲型、侵襲型、非侵襲型）分析、システム別（低侵襲型、侵襲型、非侵襲型）分析、地域別（アメリカ、カナダ、メキシコ、ドイツ、イギリス、フランス、イタリア、スペイン、中国、日本、インド、オーストラリア、韓国、中東、南アフリカ、ブラジル、アルゼンチン）分析、競争状況、市場機会・将来動向などについて調査・分析などの項目を掲載しています。並び、こちらのレポートには、LiDCO Group PLC、Baxter (Cheetah Medical Inc.)、ICU Medical Inc.、Tensys Medical Inc.、Schwarzer Cardiotek GmbH、Koninklijke Philips NV、Edwards Lifesciences Corporation、Getinge Group、GE Healthcare、Draeger Medical、Masimo、Smiths Medical、Change Healthcare、Deltex Medical, SCなどの企業情報が含まれています。 ・イントロダクション ・調査手法 ・エグゼクティブサマリー ・市場動向 ・世界の血行動態モニタリング市場規模：システム別 - 低侵襲型血行動態モニタリングの市場規模 - 侵襲型血行動態モニタリングの市場規模 - 非侵襲型血行動態モニタリングの市場規模 ・世界の血行動態モニタリング市場規模：用途別 - 実験室における市場規模 - 家庭における市場規模 - 病院における市場規模 ・世界の血行動態モニタリング市場規模：地域別 - 北米の血行動態モニタリング市場規模 アメリカの血行動態モニタリング市場規模 カナダの血行動態モニタリング市場規模 メキシコの血行動態モニタリング市場規模 … - ヨーロッパの血行動態モニタリング市場規模 ドイツの血行動態モニタリング市場規模 イギリスの血行動態モニタリング市場規模 フランスの血行動態モニタリング市場規模 … - アジア太平洋の血行動態モニタリング市場規模 中国の血行動態モニタリング市場規模 日本の血行動態モニタリング市場規模 インドの血行動態モニタリング市場規模 … - 南米/中東の血行動態モニタリング市場規模 南アフリカの血行動態モニタリング市場規模 ブラジルの血行動態モニタリング市場規模 アルゼンチンの血行動態モニタリング市場規模 … ・競争状況 ・市場機会・将来動向 |
The hemodynamic monitoring market is expected to grow with a CAGR of 4.55% in the forecasted period (2022-2027).
COVID-19 has a substantial market impact. According to the LiDCO Group PLC’s annual report for 2020, demand for hemodynamic monitoring equipment has increased from many existing customers, with significant short-term heightened demand from UK hospitals and increased demand in several other countries, including a small number of monitors sold in Wuhan, China. Furthermore, some COVID-19 patients develop complications such as sepsis and require intensive care, and there is strong clinical evidence that using advanced hemodynamic monitoring improves patient outcomes. Hence, this is also likely to create more demand for the products till the pandemic ends.
The key factors propelling the growth of this market are an increase in the number of critically ill geriatric cases, a rise in the prevalence of cardiac disorders and diabetes, increasing demand for home-based and non-invasive monitoring systems, and an increase in the number of people suffering from hypertension. As per the World Health Organization’s Fact of 2021, an estimated 1.28 billion adults aged 30-79 years worldwide have hypertension. As per the same source, Cardiovascular diseases (CVDs) are the leading cause of death globally, taking an estimated 17.9 million lives each year, an estimated 32% of all the deaths worldwide. Hence the prevalence of cardiac disorders and hypertension will likely boost the market growth.
New techniques of hemodynamic monitoring have the potential to advance the management of the cardiovascular patient during postoperative care and anesthesia as they provide accurate and repeatable measurements that can be used to detect hemodynamic alterations and their causes, optimize hemodynamic conditions such as oxygen delivery to the tissues, and provide feedback on the adequacy of therapeutic interventions. The transition from static to dynamic variables to assess requirements such as cardiac preload and fluid responsiveness, as well as the change to less invasive or noninvasive monitoring techniques, are also driving the market growth.
Thus, the market is expected to show growth over the forecast period. However, Increasing incidences of complications associated with an invasive monitoring system and stringent FDA guidelines for approval of new systems may hinder the growth of the market.
Hemodynamic Monitoring Market Trends
Minimally Invasive Monitoring Systems is Expected to Hold High Market Share Over the Forecast Period
In the system segment of the market, minimally invasive monitoring systems are believed to have the largest market size and are expected to witness significant growth during the forecast period.
The minimally invasive systems help track stroke volume continuously and offer dynamic information on fluid responsiveness. Some systems assess volumetric preload variables, while others highlight the continuous measurement of central venous saturation with proprietary catheters. These variables of minimally invasive procedures and cardiac output deliver improved hemodynamic monitoring.
There is a recent advancement in echocardiography devices known as a transesophageal echocardiography device with a miniaturized probe, which is now used for continuous hemodynamic assessment. These monitoring systems have made hemodynamic calculations easier, gaining healthcare providers’ attention, thus, resulting in the market’s growth. Additionally, the market players for reaching out large population base are timely participating in various health conferences. For Instance, in January 2022, At Arab Health 2022, Masimo demonstrated how different solutions from the company can work together across the patient journey – from the hospital to the home and anywhere care is provided – to help care teams enhance care consistency and improve patient outcomes. The company shoed its non-invasive monitoring solutions.
Thus, owing to the abovementioned factors, the market segment is expected to show growth over the forecast period.
North America Dominates the Market and Expected to do the Same Over the Forecast Period
North America currently dominates the market for hemodynamic monitoring and is expected to continue its stronghold for a few more years. The United States holds the largest share of the global hemodynamic monitoring market. The growth of the United States hemodynamic monitoring market is the most notable, owing to significant market players, technologically advanced hospitals, and an increasing number of critically ill patients being treated in the region’s hospitals.
According to Edwards Lifesciences Corporation’s annual report, demand for its pressure monitoring products increased in the United States in 2020, and this trend continued through the fourth quarter. In 2021, as hospital capital spending continued to improve and COVID hospitalizations in the United States increased, there was an increase in demand for pressure monitoring.
Moreover, with increasing United States Food and Drug Administration (FDA) approvals for monitoring devices and new product launches in the United States hemodynamic monitoring market is expected to grow during the forecast period. For instance, in September 2021, Caretaker Medical landed FDA clearance for its blood pressure and hemodynamic patient monitoring system VitalStream. Also, in March 2021, Fifth Eye, a Michigan-based real-time clinical analytics company, announced that the Food and Drug Administration had granted DE Novo classification for its Analytic for Hemodynamic Instability (AHI) tool.
Thus, owing to the abovementioned factors, the market in the North American region is expected to show growth over the forecast period.
Hemodynamic Monitoring Market Competitor Analysis
The hemodynamic monitoring market is highly competitive and consists of several major players. In terms of market share, few significant players currently dominate the market. However, with technological advancements and product innovations, mid-size to smaller companies are increasing their market presence by introducing new devices with fewer prices. Companies like Getinge Group, Koninklijke Philips NV, Edwards Life Sciences Corporation, GE Healthcare, and LiDCO Group hold substantial shares in the market.
Additional Benefits:
- The market estimate (ME) sheet in Excel format
- 3 months of analyst support
1 INTRODUCTION
1.1 Study Assumptions and Market Definition
1.2 Scope of the Study
2 RESEARCH METHODOLOGY
3 EXECUTIVE SUMMARY
4 MARKET DYNAMICS
4.1 Market Overview
4.2 Market Drivers
4.2.1 Increasing Critically Ill Geriatric Population
4.2.2 Rise in the Prevalence of Cardiac Disorders and Diabetes
4.2.3 Technological Advanements
4.3 Market Restraints
4.3.1 Increasing Incidences of Complications Associated with Invasive Monitoring Systems
4.3.2 Stringent FDA Guidelines for Approval of New Systems
4.4 Porter’s Five Forces Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry
5 MARKET SEGMENTATION (Market Size by Value – USD million)
5.1 By System
5.1.1 Minimally Invasive Monitoring Systems
5.1.2 Invasive Monitoring Systems
5.1.3 Non-invasive Monitoring Systems
5.2 By Application
5.2.1 Laboratory-based Monitoring Systems
5.2.2 Home-based Monitoring Systems
5.2.3 Hospital-based Monitoring Systems
5.3 Geography
5.3.1 North America
5.3.1.1 United States
5.3.1.2 Canada
5.3.1.3 Mexico
5.3.2 Europe
5.3.2.1 Germany
5.3.2.2 United Kingdom
5.3.2.3 France
5.3.2.4 Italy
5.3.2.5 Spain
5.3.2.6 Rest of Europe
5.3.3 Asia-Pacific
5.3.3.1 China
5.3.3.2 Japan
5.3.3.3 India
5.3.3.4 Australia
5.3.3.5 South Korea
5.3.3.6 Rest of Asia-Pacific
5.3.4 Middle East
5.3.4.1 GCC
5.3.4.2 South Africa
5.3.4.3 Rest of Middle-East
5.3.5 South America
5.3.5.1 Brazil
5.3.5.2 Argentina
5.3.5.3 Rest of South America
6 COMPETITIVE LANDSCAPE
6.1 Company Profiles
6.1.1 LiDCO Group PLC
6.1.2 Baxter (Cheetah Medical Inc.)
6.1.3 ICU Medical Inc.
6.1.4 Tensys Medical Inc.
6.1.5 Schwarzer Cardiotek GmbH
6.1.6 Koninklijke Philips NV
6.1.7 Edwards Lifesciences Corporation
6.1.8 Getinge Group
6.1.9 GE Healthcare
6.1.10 Draeger Medical
6.1.11 Masimo
6.1.12 Smiths Medical
6.1.13 Change Healthcare
6.1.14 Deltex Medical, SC
7 MARKET OPPORTUNITIES AND FUTURE TRENDS